Install
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Numerai Completes Third Strategic NMR Buyback, Bringing Total Repurchases to $3.2 Million
1+ mon, 3+ week ago (250+ words) San Francisco, CA, July 17th, 2026, Chainwire Crowdsourced Hedge Fund Completes Third Open-Market Purchase as Contributor Network and Assets Continue to Grow Numerai, the decentralized hedge fund powered by crowdsourced machine learning, today announced the completion of a third strategic purchase of…...
Boris FX Acquires iZotope
2+ mon, 5+ day ago (238+ words) Boris FX has announced the acquisition of iZotope. Its audio production tools include RX, Ozone, Neutron and Nectar. The acquisition positions Boris FX as a unified home for professional tools spanning the full spectrum of audio and video post-production. iZotope…...
Aquis weekly movers: Lift Global Ventures acquires stake
2+ mon, 1+ week ago (352+ words) Lift Global Ventures (LON: LFT) has bought a 2.18% stake in FourJaw Manufacturing Analytics, which is developing AI and machine learning technology for manufacturing, for £150,000 in shares at 1.5p each. The share price jumped 64.3% to 0.575p. WeCap (LON: WCAP) investee company WeShop has…...
Tower Research hired Citadel Securities' former head of ETF quant research
2+ mon, 2+ week ago (185+ words) eFinancialCareers He spent over eight years at Citadel Securities in a number of roles, including a three-year stint as its head of ETF quantitative research (capitalizing on price inefficiencies between an ETF and its underlying products) Dolivet is a veteran…...
Walter Capital invests in Evovest
3+ mon, 1+ week ago (240+ words) Montreal-based Evovest applies AI and machine learning to its equity-selection process Walter Capital Management has announced a minority investment in Evovest, a Montreal-based portfolio management firm that uses AI and machine learning in its investment selection process. No financial details…...
HarbourVest Partners Acquires $21 Million Stake in Generate Biomedicines
3+ mon, 1+ week ago (382+ words) HarbourVest Partners has established a significant new investment position in Generate Biomedicines (NASDAQ:GENB) during the opening quarter of 2026. As reported by Detik Finance, the institutional fund acquired 1,722,210 shares of the biotechnology firm. The total transaction value reaches an estimated…...
Arteris Director Trims a Stake He's Been Selling All Year
4+ mon, 3+ day ago (227+ words) The Motley Fool - This sale represented 13.75% of Viana's aggregate position at the time of the transaction. - All shares sold were held via the Viana Family Trust; direct holdings remain unchanged at 20,840 shares, with 104,620 shares remaining indirectly. - Ongoing sales reflect a…...
/C O R R E C T I O N -- Global X Investments Canada Inc./
4+ mon, 4+ day ago (506+ words) In the news release, Global X Announces Accumulating Unit Series for 'Cash Alternative' ETFs and Ticker Symbol Change for the Global X Artificial Intelligence & Technology Index ETF, issued 08-May-2026 by Global X Investments Canada Inc. over PR Newswire, we are…...
Descartes Systems Group Completes $28M Acquisition of Idelic for Fleet Safety and AI-Driven Predictive Analytics - News and Statistics
4+ mon, 2+ week ago (340+ words) Descartes Systems Group Acquires Idelic for $28 Million to Boost Fleet Safety IndexBox Search across reports, market insights, and blog stories. Descartes Systems Group Acquires Idelic for $28 Million to Boost Fleet Safety Descartes Systems Group has completed its acquisition of the…...
Neurocrine, eying ‘blockbuster in the making,’ strikes its largest-ever M&A deal with $2.9B Soleno buyout
5+ mon, 1+ week ago (688+ words) Neurocrine Biosciences, forever a possible M&A target in the biopharma industry, is making a major acquisition itself. Neurocine has reached a deal to acquire Soleno Therapeutics for $2.9 billion, bagging recently FDA-approved Vykat XR (diazoxide choline), the first therapy for…...